Week of April 25, 2022 | Vol. 11, Issue 17 |
|
|
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates
Quick Links
Contact Information
Managing Director
Business Development
Managing Director
Head of M&A and Capital Advisory
|
|
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
|
|
Events Hosted or Attended by Bourne Partners
|
|
|
|
April 23-26, 2022 - Palm Beach, FL
|
|
|
|
May 17-19, 2022 - Philadelphia, PA
|
|
|
|
May 24-26, 2022 - New York City, NY
|
|
|
|
June 13-16, 2022 - San Diego, CA
|
|
|
|
June 19-23, 2022 - Chicago IL
|
|
|
|
August 27-29, 2022 - Boston, MA
|
|
|
|
October 2022 - Charlotte, NC
|
|
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
|
|
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
|
|
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions. |
|
|
|
Pharma & Biotech
6 transactions totaling $2,540 million
Supplies, Equipment & Services
14 transactions totaling $391 million
Healthcare IT & Managed Care
5 transactions totaling $120 million
Healthcare Facilities & Distributors
4 transactions totaling $63 million
|
|
|
|
Pharma & Biotech
40 transactions totaling $720 million
Supplies, Equipment & Services
29 transactions totaling $434 million
Healthcare IT & Managed Care
14 transactions totaling $89 million
Healthcare Facilities & Distributors
5 transactions totaling $61 million
|
|
|
|
Pharma & Biotech
24 transactions totaling $1,359 million
Supplies, Equipment & Services
5 transactions totaling $60 million
Healthcare IT & Managed Care
1 transaction totaling $4 million
Healthcare Facilities & Distributors
0 transactions
|
|
TRADING COMPS
A Breakdown of Relevant Trading Multiples
|
|
|
|
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.
For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table.
Note: data reflects prior week close.
|
|
MARKET REPORTS
Insight Into Healthcare Related Industries
|
|
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
|
|
Project Gateway
Sell-side | Pharma | Generic pharmaceuticals
Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Panther
[Buy/sell]-side| [Pharma, CDMO, Generic Pharma, etc.] | [What the company does]
|
|
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
|
|
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
|
|
After a bustling, record-setting 2020 for private biotechs raising cash, the bar heading into 2021 was exceptionally high. Turns out, private investors elected to just take the bar and do pull-ups, breaking 2020’s record by a whopping 26%.
It’s the kind of jump that’s genuinely hard to believe. Biotechs raised more than $22 billion in private funds in 2020, rebounding after a slow 2019. Then 2021 came along, and the industry's young companies ginned up $28.5 billion in cash, according to Evaluate Vantage's year-end report.
Vantage found that 216 fundraising rounds equaled or eclipsed $50 million last year, compared to 173 in 2020. Nearly 100 rounds equaled or eclipsed $100 million (93) compared to 63 in 2020.
|
|
April 19, 2022 - Fierce Biotech
|
Regeneron plans to show there is more to skin cancer than PD-1 inhibitors through the $250 million acquisition of Checkmate Pharmaceuticals for the lead immuno-oncology asset vidutolimod. |
|
April 20, 2022 - Fierce Pharma
|
As weeks turn into months, the war in Ukraine has prompted a mass exodus of businesses and consumer brands from Russia. |
|
April 21, 2022- Fierce Biotech
|
Data-driven therapeutics company Octant Bio is exploring new frontiers of drug development with $80 million in-pocket and a freshly signed Big Pharma partnership. |
|
April 21, 2022- Fierce Biotech
|
Like a young joey carried safely in a marsupial's pouch, so too will devicemaker Phenox be tucked into its new parent company, the aptly named Wallaby Medical. |
|
TannerMAP works across the broad spectrum of pharma services, creating opportunities that benefit manufacturers and patients alike. Learn more about the division from industry veterans and Tanner EVPs, Rob Keel and John Lagus. |
|
Tanner Pharma announced last week its expansion to Ireland with the opening of a new office space in Cork, the country’s third largest city. The new location was selected after many months of travel and research by Tanner’s executive team.
|
|
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.
|
|
|
|
|
|
|
